Abstract Metabolic syndrome (MS) in obese Zucker rats (OZR) is associated with impaired skeletal muscle performance and blunted hyperemia. Studies suggest that reduced O 2 diffusion capacity is required to explain compromised muscle performance and that heterogeneous microvascular perfusion distribution is critical. We modeled tissue oxygenation during muscle contraction in control and OZR skeletal muscle using physiologically realistic relationships. Using a network model of Krogh cylinders with increasing perfusion asymmetry and increased plasma skimming, we predict increased perfusion heterogeneity and decreased muscle oxygenation in OZR, with partial recovery following therapy. Notably, increasing O 2 delivery had less impact on VO 2 than equivalent decreases in O 2 delivery, providing a mechanism for previous empirical work associating perfusion heterogeneity and impaired O 2 extraction. We demonstrate that increased skeletal muscle perfusion asymmetry is a defining characteristic of MS and must be considered to effectively model and understand blood-tissue O 2 exchange in this model of human disease.
Introduction
The growing incidence and prevalence of the metabolic syndrome and associated type 2 diabetes mellitus represent one of the greatest challenges to public health facing developed economies worldwide [1, 2] . The metabolic syndrome is generally defined as the combined presentation of obesity, impaired glycemic control, atherogenic dyslipidemia, and moderate hypertension, with the additional contributing conditions of pro-oxidant, pro-thrombotic, and pro-inflammatory phenotypes [3] [4] [5] . This clinical condition is present in an enormous and growing number of afflicted people worldwide, it has a powerful influence on reducing patient quality of life and life expectancy, and it causes enormous increases to the direct and indirect economic costs that must be borne by society as a result of its negative effects on health outcomes [1, 2] . These considerations mandate detailed investigation into this multipathology state.
In the general population [6] and in specific elements of the metabolic syndrome such as type 2 diabetes mellitus (T2DM; ref. 7) , aerobic exercise capacity as measured by maximal oxygen consumption (VO 2max ) is the strongest clinical predictor of mortality. Further, in both T2DM and metabolic syndrome, exercise capacity has been demonstrated to be reduced [8] [9] [10] . While the precise mechanisms underlying impaired exercise capacity in these states remain unclear, there are distinctive mechanistic hints in Associate Editor Craig Stolen oversaw the review of this article the existing literature. In both human and animal studies of these states, hyperemic responses to exercising muscle are reduced with manifestation of the metabolic syndrome [11, 12] , yet oxygen extraction not only can fail to increase to compensate for the ischemia but can be reduced itself [11, 13] . Given that mitochondrial capacity exceeds the oxygen delivering capacity of the vasculature [14] , the coincidence of impaired blood flow and impaired oxygen extraction cannot be explained through reduced mitochondrial demand or function. Understanding these apparent phenotypic contradictions requires detailed mechanistic study of O 2 transport and consumption comparing theoretical predictions to empirical data.
The obese Zucker rat (OZR; fa/fa) represents an excellent animal model of the metabolic syndrome with high utility in terms of comparing cardiovascular (dys)function to pathology in human subjects. OZR develops the metabolic syndrome due to chronic hyperphagia secondary to profound leptin resistance and rapidly develops the systemic phenotypes listed above to comparable levels of severity with those identified in human subjects. Also, similar to health outcomes in humans, OZR exhibiting the metabolic syndrome suffers from a progressive vasculopathy that ultimately develops into overt peripheral vascular disease (PVD; ref. 15) , albeit one without the development of significant atherosclerotic lesions within macrovessels.
Recent experimental studies have revealed significant impairments to the fatigue resistance (i.e., the ability to maintain contractile performance over time) of in situ skeletal muscle of OZR as compared to that in lean Zucker rats (LZRs) [11, 16] . The extent of these impairments has been generally correlated with reductions in bulk blood flow and hyperemic responses to the elevated metabolic demand [11] . However, the relationship between fatigue and reduced blood flow is not particularly robust, and there is potential that factors beyond simple bulk perfusion could be responsible for the functional manifestation of PVD in metabolic syndrome.
We have previously published observations of reduced blood flow (Fig. 1a) , reduced oxygen extraction (Fig. 1b) , increased muscle fatigue associated with reduced diffusion capacity (Fig. 1c) , and increased perfusion heterogeneity (Fig. 1e ) in the OZR [11, [17] [18] [19] . Perfusion heterogeneity was quantified using the parameter γ (Fig. 1d) , defined as the fraction of total blood flow diverted to the higher flow daughter vessel at a microvascular bifurcation. Pharmacological intervention (e.g., TEMPOL; 1-oxyl-2,2,6,6-tetramethyl-4-hydroxypiperidine, a cell permeable superoxide dismutase mimetic which acts as a powerful antioxidant) correcting this perfusion heterogeneity in the smallest arterioles (3a-5a) normalizes oxygen extraction, and intervention correcting both bulk blood flow and perfusion heterogeneity (using a combined treatment of TEMPOL, the α 1 /α 2 adrenoceptor antagonist phentolamine and the TxA 2 /PGH 2 receptor blocker SQ-29548) fully restores oxygen uptake in the OZR to LZR levels [11, 17, 18] . Therefore, it is of interest to be able to quantitatively test the hypothesis that oxygen supply from blood to skeletal muscle is a major limiting factor for muscle contractile performance under conditions of elevated metabolic demand within OZR and, if observed, to define factors limiting oxygen delivery.
In this work, a computational model of oxygen transport within skeletal muscle was constructed based on the classical Krogh cylinder-type model [20] , which has been further extended to account for capillary wall transport barrier, myoglobin-facilitated diffusion, and MichaelisMenten kinetics of oxygen consumption [21] . The constructed computational model was then applied to analyze oxygenation levels and metabolic rates using experimental data on bulk tissue blood flow and blood oxygen tensions measured from in situ blood-perfused contracting skeletal muscle of LZR and OZR and reported in a previous publication [11] . The predictions of this model were compared to previously published empirical observations to determine the effects of perfusion heterogeneity in an idealized microvascular network taking into account phase separation (i.e., erythrocytes from plasma) effects at bifurcations [22] .
Materials and Methods
Microvascular Network Model We have previously reported increased microvascular blood flow heterogeneity in OZR compared with that in LZR [17] [18] [19] . To test the hypothesis that the associated mismatch between oxygen supply and working capacity [11] is caused by the flow heterogeneity, an idealized microvascular network (shown in Fig. 2a ) was applied to examine impacts of flow heterogeneity on oxygen transport on the microvascular level. Empirical data from a previous publication [11] was used for this analysis.
The idealized microvascular network employed in this analysis was based on Murray's cube law [23] and assumed a fully symmetric vascular tree (i.e., all vessels of the same generation are the same length and diameter). The resulting vascular tree is consistent with the L-system fractal formalism of Zamir [24] , has recently been applied to assess the impact of the endothelial glycocalyx on microvascular blood flow distribution [25] , and has been extensively validated as a reasonable approximation of microvascular branching architecture in vivo [26] . The idealized microvascular network included in this analysis branched from a 192-μm parent vessel to 6 μm diameter capillaries over the course of 15 vessel generations.
At each microvascular bifurcation, the uneven distribution of blood flow into the daughter branches results in heterogeneity of downstream discharge hematocrits as described by the following equation [22] 
where logit function is defined as
The ratios of bulk blood volume flow and erythrocyte volume flow are defined as
respectively, with subscript 1 denoting daughter branch 1. During the simulations, the ratio of bulk blood volume flow (γ B ) was varied from 0.5 to 0.7 (using notation [17] consistent with our previously published perfusion heterogeneity analyses), and the discharge hematocrits in the daughter branches were calculated using Eqs. 2-4 for all vessel generations. In this work, arteriolar oxygen delivery is neglected; thus, inlet PO 2 to each capillary is assumed to be equal to arterial PO 2 , a reasonable assumption under conditions of high flow and high oxygen demand. Then, the oxygen transport was calculated for each capillary using lookup table of C TV values simulated from a range of representative discharge Hct and F values for LZR or OZR (see Fig. 2b ). Mitochondrial demand (V max ) in all cases was adjusted to recreate whole-muscle VO 2 for LZR at each level of stimulation without perfusion heterogeneity, consistent with observations of minimal perfusion heterogeneity in the LZR [17] [18] [19] .
Krogh Cylinder-Type Model In the Krogh cylinder-type model, the tissue is assumed to consist of uniformly spaced cylinders, and each tissue cylinder is supplied by a capillary with perfusing blood flow within its volume. The oxygen carried by blood supports local metabolic demand through diffusion across the capillary wall and into the skeletal muscle cell. The geometry of the Krogh cylinder-type model is shown in Fig. 2b .
Governing Equations
The Krogh cylinder-type model is described by two ordinary differential equations for radial and axial oxygen transport, respectively [1, 25] .
Oxygen movement in the radial direction: Based on Fick's law of diffusion and mass transport, the radial oxygen transport is described by
where D denotes the molecular diffusivity of oxygen, C * denotes the modified tissue oxygen concentration accounting for myoglobin-facilitated diffusion, and VO 2 denotes oxygen consumption rate in the tissue.
The modified tissue oxygen concentration C * is defined as
where D Mb denotes the molecular diffusivity of myoglobin, C Mb denotes the tissue myoglobin concentration, V m denotes the molecular volume of oxygen, and S Mb denotes the myoglobin saturation level. The myoglobin saturation level is calculated from
where C 50,Mb denotes half-maximal myoglobin saturation O 2 concentration. The oxygen consumption rate (M) is assumed to follow Michaelis-Menten kinetics
where V max denotes the maximal mitochondrial oxygen consumption rate and K M denotes the Michaelis-Menten constant of oxygen consumption in the skeletal muscle.
Assuming that no oxygen exchange occurs across the outer boundary of the tissue cylinder (i.e., the outer boundary of the cylinder represents a local minimum of PO 2 ), a no-flux boundary condition is obtained
Q12, D1 At the interface between capillary and tissue, an oxygen permeability barrier is assumed
where D denotes the molecular diffusivity of oxygen in tissue, p w denotes cross-capillary wall permeability of oxygen, and R 2 denotes the outer radius of the tissue cylinder.
Oxygen movement in the axial direction: Since the axial oxygen gradient is much less than the radial oxygen gradient, the axial oxygen transport is assumed to be dominated by convection and is described as follows
where C T denotes the total oxygen concentration in blood, VO 2avg denotes the oxygen consumption rate averaged along the radial direction, F denotes the flow volumetric rate normalized to tissue mass, ρ tissue denotes the tissue mass density, and L denotes the capillary length. The average oxygen consumption rate (VO 2avg ) is defined as
The total oxygen concentration (C T ) is defined as
where C f denotes free oxygen concentration in plasma, C RBC denotes free oxygen concentration in red blood cells (RBCs), Hct denotes discharge hematocrit, C Hb denotes concentrations of oxygen binding sites in RBCs, and S Hb denotes hemoglobinoxygen saturation level. The hemoglobin saturation level is calculated from
where P 50,Hb denotes half-maximal hemoglobin saturation O 2 tension and n H denotes the Hill coefficient for hemoglobinoxygen binding. The free oxygen concentration in plasma and RBCs can be related to oxygen tension (PO 2 ) as
where α plasma and α RBC are oxygen solubility in plasma and RBCs, respectively. Figs. 3 and 4) . These LUTs were combined with the network perfusion model discussed above to rapidly obtain an array of single-capillary values for venous oxygen content and mean muscle oxygenation. The oxygen concentration of the mixed venous effluent was then calculated as
Finally, mean muscle PmO 2 was calculated from the mean of all single-capillary PmO 2 values.
Sensitivity Analysis Methods Microvascular perfusion heterogeneity results from a complex combination of microfluidic mechanical changes (e.g., glycocalyx degradation, capillary plugging by adherent leukocytes) and changes in vessel tone/diameter. Vessel diameter influences distribution of RBCs independently of flow distribution [22] , and it is plausible that these effects, which were not considered in our muscle oxygenation simulations, are significant in vivo. To assess this possibility, we performed a sensitivity analysis on the simulated effects of diameter randomization independent of perfusion heterogeneity. The maximum degree of flow asymmetry considered in this manuscript (γ = 0.7) can be produced by a ∼9% difference in downstream vessel diameters, assuming laminar flow. Accordingly, we simulated CvO 2 , PmO 2 , and VO 2 with up to 10% randomization of vessel diameter in each vessel segment. One hundred simulations at each degree of diameter randomization were performed, and the coefficient of variance (CV = SD/mean) of simulation results was used as a metric of the effect size of diameter randomization.
Model Parameters The parameters used in this model are taken from either the present experimental results or from validated literature values and are summarized in Table 1 .
The measured blood flow (F) and arterial oxygen tensions (P a O 2 ) were used as inputs to the computational model to simulate venous oxygen tensions (P v O 2 ). The model parameters were set up using values listed in Table 1 , except that the oxygen consumption demand (VO 2 ) at rest and at 5 Hz were generated via model optimization by minimized differences between modelpredicted and experimentally measured PvO 2 .
The Krogh cylinder-type model was implemented on a standard desktop personal computer using MATLAB (Version R2013b, MathWorks, Natick, MA). The optimization was performed using the fmincon function included in MATLAB Optimization Toolbox.
Results

Effects of Perfusion Heterogeneity on Oxygen Transport in Microvascular Networks
An idealized microvascular network (Fig. 2a) was used to examine the effects of microvascular flow heterogeneity on oxygen transport. The simulations were conducted by assuming that the mitochondrial demand (V max ) in LZR and OZR are equal and sufficient to produce measured values of VO 2 with homogeneous perfusion in the LZR. Empirical data from a previous publication [11] was used for this analysis. The results of this simulation are shown in Fig. 6 . Model simulations of PvO 2 using varying flow distributions reveal that simulated PvO 2 matches measured PvO 2 at values of γ = 0.6164 for untreated OZR, γ = 0.5562 for TEMPOL-treated OZR, and at γ = 0.5121 for LZR at 5 Hz (Fig. 6a) , indicating heterogeneous perfusion in the OZR that can be partially corrected by TEMPOL treatment. Using the model-predicted values of γ = 0.5121, 0.5562, and 0.6164 for LZR, TEMPOLtreated OZR, and untreated OZR, respectively, our model predicts a mean muscle PmO 2 of 30.4 mmHg in the LZR, 18.9 mmHg in untreated OZR, and 23.48 mmHg in TEMPOL-treated OZR (Fig. 6b) at 5 Hz, indicating muscle hypoxia during exercise in the OZR that can be partially corrected by TEMPOL treatment. Our simulations Fig. 3 Heatmaps visualizing lookup tables (LUTs) of venous oxygenation as a function of capillary hematocrit and relative blood flow. a LUT of simulated venous oxygenation in the LZR at rest. b LUT of simulated venous oxygenation in the LZR during 5 Hz contractions. Note that venous oxygenation is substantially decreased (i.e., oxygen extraction is increased) relative to rest given similar flow and hematocrit. c LUT of simulated venous oxygenation in the OZR at rest. d LUT of simulated venous oxygenation in the OZR during 5 Hz contractions. Note that venous oxygenation is substantially less than at rest and marginally less than in the OZR given similar flow and hematocrit also predict that the contributions of perfusion heterogeneity account for more than half of the total decrease in VO 2 in the OZR relative to LZR (Fig. 6c) , a majority of which is due to perfusion heterogeneity in the small 3a-5a arterioles where TEMPOL most profoundly influences perfusion heterogeneity [17] .
Results from Sensitivity Analysis
The results of our sensitivity analysis are shown in Fig. 5 . Results were largely consistent among the results for CvO 2 (Fig. 5a ), PmO 2 ( Fig. 5b) , and VO 2 (Fig. 5c) . In all cases, the CV of the oxygenation metric of interest increases quadratically with increasing diameter randomization. The influence of diameter randomization independent of perfusion heterogeneity is several orders of magnitude smaller than that of perfusion heterogeneity independent of diameter randomization. These results suggest that our muscle oxygenation analysis with varying degrees of perfusion heterogeneity was negligibly influenced by our choice to neglect possible effects from vessel tone independent of blood flow and its distribution.
Mechanisms Underlying the Effects of Perfusion Heterogeneity
To determine the mechanism(s) by which microvascular perfusion heterogeneity would theoretically reduce oxygen diffusion capacity, we compared the effects of equivalent increases or decreases in flow or hematocrit on oxygen uptake in single capillaries (Fig. 7) , using LZR 5 Hz values [11] in a single-cylinder version of our model for illustration purposes. Increasing capillary blood flow increases oxygen uptake, but not to the same degree that an equivalent decrease in capillary blood flow decreases oxygen uptake. The mean oxygen uptake of two capillaries with a fixed total blood flow supply thus decreases with increasing flow disparity between the two capillaries (Fig. 7a) . Similarly, increasing capillary hematocrit increases oxygen uptake, but not to the same degree that an equivalent decrease in capillary hematocrit decreases oxygen uptake. The mean oxygen uptake of two capillaries with a fixed total RBC flux thus decreases with increasing hematocrit disparity between the two capillaries (Fig. 7b) . Due to the plasma-skimming effect at Note that muscle oxygenation is substantially decreased relative to rest given similar flow and hematocrit. c LUT of simulated muscle oxygenation in the OZR at rest. d LUT of simulated muscle oxygenation in the OZR during 5 Hz contractions. Note that muscle oxygenation is substantially less than at rest and marginally less than in the OZR given similar flow and hematocrit microvascular bifurcations [22] , capillary flow and discharge hematocrit are positively correlated (see Fig. 7c , uses simulated γ = 0.7 distribution for illustration purposes). The effects of flow and hematocrit disparities thus synergize to produce the cumulative effects of perfusion heterogeneity.
Discussion
It has been clearly demonstrated by our group [11, 16] and by others [32] that the development of the metabolic syndrome is associated with alterations to skeletal muscle arterial and arteriolar function. These changes are correlated with impaired hyperemic responses to elevated metabolic demand, constrained oxygen uptake (VO 2 ) across skeletal muscle, and impaired fatigue resistance of in situ blood perfused skeletal muscle. However, beyond a restricted number of studies, there has been much less effort dedicated to determining how these key parameters relate to one another. The purpose of this study was to take the first steps into developing a computational model for microvascular perfusion under the conditions of the metabolic syndrome and to model, based on established literature values and original data from the OZR model of the metabolic syndrome, how microvascular function might be altered based on the underlying principles of mass transport and exchange. This is intended to be a first step in a larger effort to develop predictive models and biosimulations of sufficient veracity as to be useful for hypothesis development and informing experimental design. These models will be refined with the ultimate goal of application to clinical settings to inform a better understanding of conditions affecting microvascular function, cardiorespiratory fitness, and response to clinical intervention.
A major initial interpretation of the results from the present simulations is that the striking similarity determined in the heatmaps (Figs. 3 and 4) for oxygen transport and exchange between LZR and OZR is conceptually in contrast to all of the functional (i.e., muscle performance) data collected to date. If oxygen transport is minimally affected in between LZR and OZR using flow characteristics, then differences in perfusion and/or distribution are required to explain the discrepancy in outcomes. This highlights the importance of introducing perfusion heterogeneity into our simulations of microvascular perfusion in the OZR manifesting metabolic syndrome in [31] order to more accurately understanding the system function in this challenged state. Our present simulations show that perfusion heterogeneity is mathematically sufficient to account for our previously published observations of increased venous oxygenation (Fig. 6a) in the OZR and sufficient to explain why venous oxygenation is partially corrected by TEMPOL treatment [11] . Perfusion heterogeneity is also mathematically sufficient to account for literature reports of muscle hypoxia (Fig. 6b ) in the OZR [33] . Our model predicts that this muscle hypoxia is partially relieved by TEMPOL treatment. Although this prediction has not yet been directly tested, it does provide a plausible explanation for partial recovery of oxygen uptake with TEMPOL treatment [11] . Finally, our model predicts that perfusion heterogeneity accounts for a majority of the oxygen uptake (Fig. 6c ) defect in during 5 Hz contractions the OZR, consistent with experimental recovery of a majority of the oxygen uptake defect during 5 Hz contractions when treated with a drug cocktail that fully reverses microvascular perfusion heterogeneity [11, 17, 18] . The degree of perfusion heterogeneity required to mathematically account for oxygen transport differences between OZR and LZR in our simulation is not only qualitatively but also quantitatively similar to experimentally determined values of γ in LZR and OZR [17, 18] . Finally, our simulations provide a mechanism by which perfusion heterogeneity results in impaired oxygen transport (Fig. 7) . Namely, an individual capillary's oxygen uptake is more sensitive to decreases in oxygen supply than to increases of similar magnitude. Similar to ventilationperfusion mismatch in the lung, over-perfused vessels cannot fully compensate for under-perfused vessels.
Our simulations show that microvascular perfusion heterogeneity is mathematically sufficient to account for oxygen transport defects in the OZR not caused by reduced bulk blood flow. We have also previously published experiments showing that perfusion heterogeneity is empirically necessary to account for these same defects [17] [18] [19] . Given the theoretical sufficiency and empirical necessity of perfusion heterogeneity to account for the OZR phenotype, it is very likely that (1) our model describes tissue-level oxygen transport to a reasonable degree of accuracy, and (2) perfusion heterogeneity is a key pathological feature of the metabolic syndrome.
In contrast with this manuscript, the bulk of the scientific literature discussing exercise capacity in the metabolic syndrome and T2DM focuses on the total mount blood flow delivered to exercising muscle. Given the previously demonstrated impairments to vascular/ arteriolar function in the skeletal muscle of OZR [16] , the progressive rarefaction of the microvascular networks [34] and the reduction to bulk perfusion to the skeletal muscle across metabolic intensities [11] , impaired oxygen transport is not particularly surprising. However, combining our present model results with our previous findings of heterogeneous microvascular blood flow distribution using both direct microvascular visualization [16] [17] [18] and tracer washout kinetics [19] , an alternate interpretation of literature data suggests that increased muscle fatigue in OZR may also reflect an increasingly heterogeneous distribution of perfusion within microvascular networks. Microvascular perfusion heterogeneity contributes to impaired muscle function by causing reduced O 2 extraction and an elevated PvO 2 . Our simulations and previously published experiments support the hypothesis that perfusion heterogeneity, along with the resulting phase separation of plasma from RBCs [22] , results in NOTE:Horizontal and vertical lines represent single-variable measures (e.g. VO2 and were not simultaneously measured).
They do NOT represent independence of axes. 6 Differences in venous oxygenation, muscle oxygenation, and perfusion heterogeneity can be predicted using a simulation of microvascular blood flow and oxygen transport. a Venous oxygenation increases with increasing perfusion heterogeneity in both the LZR and the OZR. The intersection between simulated venous oxygenation (light, dashed lines) and empirically measured venous oxygenation (bold lines) can be used to predict the degree of perfusion heterogeneity. Our model correctly predicts greater perfusion heterogeneity in the OZR and partial correction of perfusion heterogeneity with TEMPOL treatment. b The intersection between simulated muscle oxygenation (light, dashed lines) and model-predicted perfusion heterogeneity (bold lines) can be used to predict muscle oxygenation. Our model correctly predicts reduced muscle oxygenation in the OZR and also predicts partial correction of muscle oxygenation with TEMPOL treatment. c The intersections of simulated oxygen uptake (light, dashed lines) with empirically measured oxygen uptake (bold lines) and with modelpredicted oxygen uptake without perfusion heterogeneity in the OZR (light, dotted line) can be used to predict the relative contributions of various oxygen transport parameters to the observed oxygen uptake defect. Our model predicts that perfusion heterogeneity in small (3a-5a) arterioles plays a major role in reduced oxygen uptake in the OZR failure to compensate for reduced blood flow in OZR with increased oxygen extraction. Collectively, these echoes of previously published data in our simulations lend credibility to the notion that microvascular perfusion heterogeneity is necessary and sufficient to account for experimentally observed barriers to oxygen transport in OZR. Although there are assumptions within our model that require further refinement (e.g., neglecting axial O 2 diffusion, neglecting heterogeneous non-Kroghian capillary morphology, neglecting microscopic variances in blood O 2 content), the broad consistency between our computational results, our previously published experimental results, and the broader published literature suggests that our simulations were sufficient to predict observed oxygen transport phenotypes from first principles. These findings suggest that clinical strategies aiming to improve bulk blood flow without also improving perfusion may have limited impact in the metabolic syndrome. Microvascular perfusion heterogeneity represents an unaddressed therapeutic target for improving tissue oxygenation and muscle function.
Author Contributions PMM, FW, and JCF researched data. PMM, FW, and JCF wrote manuscript. All reviewed/edited manuscript. All contributed to discussion. Fig. 7 Analysis of perfusion heterogeneity effects at a single bifurcation reveals the mechanisms by which perfusion heterogeneity interferes with oxygen transport. a Increasing flow through one capillary while subtracting the same amount of flow from another capillary results in a greater decrease in oxygen uptake by the under-perfused capillary than the corresponding increase in oxygen uptake by the over-perfused capillary. This effect occurs independently of hematocrit effects. b Increasing hematocrit in one capillary while subtracting the same number of RBCs from another capillary results in a greater decrease in oxygen uptake by the low-hematocrit capillary than the corresponding increase in oxygen uptake by the high-hematocrit capillary. This effect occurs independently of flow effects. c Capillary flow and hematocrit are correlated at the single-capillary level, and flow heterogeneity results in hematocrit heterogeneity. These consequences of the plasma-skimming effect cause the effects of flow heterogeneity and hematocrit heterogeneity to synergize in reducing oxygen uptake under conditions of microvascular perfusion heterogeneity
